Determine areas of misalignment, differences, and gaps present in the current benefits and compensation system, based on the
external benchmarking data. What are the key areas of the current system that are misaligned with the competition?
Based on the strengths and weaknesses of each plan, determine Emerging Pharmaceuticals rewards components that should be increased,
reduced, or stay the same, and provide your rationale.
Compare qualitative input data and quantitative analysis with the organization’s employee demographic data to determine the degree of the
existing population that will be affected by the proposed changes. In other words, what is the overall impact of each proposed change?
